6 research outputs found
Exotic hadrons bend the rules
The equipment used to measure the aerosolized particle sizes (Mastersizer 2000: Malvern Instruments Ltd., Worcestershire, UK). (DOCX 251 kb
Additional file 1: Table S1. of The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases
Five different conditions were tried for the nebulization of amikacin sulphate. (DOCX 24 kb
Additional file 2: Table S2. of The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases
Nebulizing time and speed, final remaining dose and the particle size in the compressor nebulizer. A digital weighing scale was used to measure the mean nebulizing speed and the final remaining dose. The particle sizes were measured using a Mastersizer 2000 (Malvern Instruments Ltd., Worcestershire, UK). (DOCX 186 kb
Additional file 1: Table S1. of Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series
Comparison of patient characteristics between patients receiving AMK and patients not receiving AMK (DOCX 14 kb
Additional file 5: Figure S2. of The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases
Particle sizes and solution volumes in condition 1, condition 2 and condition 5. The aerosolized particle sizes were measured using a Mastersizer 2000 (Malvern Instruments Ltd., Worcestershire, UK). (DOCX 243 kb